Carregant...
Miniatura

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

Llicència de publicació

cc-by-nc-nd (c) Elsevier B.V., 2019
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/173171

Utility of the MoCA for cognitive impairment screening in long-term psychosis patients

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Cognitive impairment is a key feature in patients with psychotic disorders. The Montreal Cognitive Assessment (MoCA) is a brief tool that has been shown to be effective in identifying mild cognitive impairment and early dementia. This study explores the usefulness of this instrument to detect cognitive impairment in long-term psychotic disorders. One hundred-forty stabilized patients were re-evaluated more than 15 years after a First Episode of Psychosis (FEP). Patients were psychopathologically assessed, and the MoCA test and MATRICS Consensus Cognitive Battery (MCCB) were administered. Two cut-off scores for cognitive impairment using the MCCB were applied (T score <40 and < 30). Concurrent validation was found between the total scores of the MoCA and MCCB. We also found significant associations between 5 out of 7 MoCA subtests (visuospatial-executive, attention, language, abstraction and delayed recall) and MCCB subtests but not for the naming and orientation MoCA subtests. Receiver operating characteristic (ROC) analysis suggested a <25 cut-off for cognitive impairment instead of the original <26. Our results suggest that the MoCA test is a useful screening instrument for assessing cognitive impairment in psychotic patients and has some advantages over other available instruments, such as its ease-of-use and short administration time.

Matèries (anglès)

Citació

Citació

GIL-BERROZPE, Gustavo j., SÁNCHEZ-TORRES, Ana m., GARCÍA DE JALÓN, Elena, MORENO-IZCO, Lucía, FAÑANÁS SAURA, Lourdes, PERALTA, Víctor, CUESTA, Manuel j., SEGPEPs group. Utility of the MoCA for cognitive impairment screening in long-term psychosis patients. _Schizophrenia Research_. 2019. Vol. 216, núm. 429-434. [consulta: 25 de gener de 2026]. ISSN: 0920-9964. [Disponible a: https://hdl.handle.net/2445/173171]

Exportar metadades

JSON - METS

Compartir registre